Roswell Park biotech spinoff to develop new cancer therapies

BUFFALO, NY (WIVB) –  Roswell Park Cancer Institute is launching a spinoff company that will develop new cancer therapies.

Tactiva Therapueutics LLC is  a biotech firm, one of the Start-Up NY companies.  It is expected to generate 18 jobs over the next five years.

“Tactiva has developed a unique approach that shows great promise advancing one of our key goals “ said Roswell Park President and CEO Candace Johnson.  It will, “develop our best ideas and get them quickly to the patients who can benefit most from them.”

Clinical trials in ovarian, pancreatic, lung and prostate cancers will be just some of the projects Tactiva will tackle.

Tactiva has a unique approach in using a patient’s own immune cells, multiply them and then inject them back into the patient to attack cancer cells. provides commenting to allow for constructive discussion on the stories we cover. In order to comment here, you acknowledge you have read and agreed to our Terms of Service. Commenters who violate these terms, including use of vulgar language or racial slurs, will be banned. Please be respectful of the opinions of others. If you see an inappropriate comment, please flag it for our moderators to review. Note: Comments containing links are not allowed.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s